A meta-analysis on selective versus comprehensive neck dissection in oral squamous cell carcinoma patients with clinically node-positive neck.
Lizhong Liang, Tonghan Zhang, Qianying Kong...
https://pubmed.ncbi.nlm.nih.gov/26500065/Actively Recruiting
Led by Kolhapur Cancer Centre - Cancer Centers of America · Updated on 2026-08-04
80
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to compare two surgical approaches for patients with oral cavity squamous cell carcinoma OCSCC who have cancer spread to neck lymph nodes clinically node-positive, cN1. The trial evaluates whether a less extensive selective neck dissection levels I-IV provides outcomes comparable to a more extensive modified neck dissection levels I-V while reducing surgical complications. The study addresses the uncertainty around the best extent of neck surgery to balance cancer control with quality of life. Participants will be randomly assigned to one of two groups selective neck dissection removing lymph node levels I-IV, or modified neck dissection removing levels I-V while preserving key nerves and muscles when possible. Both groups will also receive surgical removal of the primary oral tumor, with reconstruction and additional treatments based on pathology results and standard care. This trial will provide high-quality evidence comparing these two surgical techniques. During the study, participants will undergo assessments of regional cancer recurrence over three years, quality of life using the Neck Dissection Impairment Index, and shoulder function at multiple time points up to two years after surgery. Other measures include overall survival, disease-free survival, nodal involvement analysis, and monitoring of surgical complications such as chyle leak. The total follow-up period extends up to three years to evaluate long-term outcomes and function.
CONDITIONS
Study Comparing Limited and Extensive Neck Surgery in Oral Cancer Patients With Neck Spread
M
Maroti B Wadewale, MDS, FHNO
P
Parag J Watve, MS, FHNS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kolhapur Cancer Centre - Cancer Centers of America
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single surgical procedure with recovery period
Participants undergo surgery to remove the primary oral cavity tumor along with either selective neck dissection (levels I-IV) or modified neck dissection (levels I-V). Reconstruction and any additional therapy are provided based on pathology results and standard care.
1 baseline visit and multiple follow-up visits for assessments
Duration - Up to 3 years
Participants are monitored for up to three years after surgery to assess cancer recurrence, survival, shoulder function, quality of life, and surgical complications.
Regular visits at 1 week, 1 month, 3 months, 6 months, 1 year, and 2 years post-surgery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Lizhong Liang, Tonghan Zhang, Qianying Kong...
https://pubmed.ncbi.nlm.nih.gov/26500065/Yoo Seob Shin, Yoon Woo Koh, Se-Heon Kim...
https://pubmed.ncbi.nlm.nih.gov/23225810/Gouri H Pantvaidya, Pooja Pal, Abhishek D Vaidya...
https://pubmed.ncbi.nlm.nih.gov/23996343/Syed Salman Hashmi, Akbar Abbas, Amna Bukhari...
https://pubmed.ncbi.nlm.nih.gov/36405475/Kolhapur Cancer Centre - Cancer Centers of America
Lead Sponsor